Protection of the peptide glutathione by complex formation with alpha-cyclodextrin: NMR spectroscopic analysis and stability study.
The main objective of this work was to investigate the complexation mechanism of the tripeptide glutathione with alpha-cyclodextrin (alpha-CyD). The final purpose was to explore the possibility of using this complexation approach for preserving the stability of this peptide in all biological environments relevant for oral drug delivery. The complexes between the peptide and alpha-CyD were formed in aqueous solution and the complexation mechanism was investigated using different (1)H NMR experimental approaches. The resulting complexes were also studied with respect to their ability to protect the peptide against proteolytic degradation by the exopeptidase, gamma-glutamyltranspeptidase. The NMR experiment, 1D-saturation transfer NOE difference (STD), evidenced the interaction between alpha-CyD and glutathione. The binding constants, calculated by a titration method, were in the range of 55-70 M(-1) at 25 degrees C and in the range 68-72 M(-1) at 37 degrees C. Moreover, from the 1D-pulse field gradient spin echo-transverse-rotating frame nuclear Overhauser (PFGSE-T ROESY) spectra it was concluded that alpha-CyD binds preferably to the l-glutamate (side chain) moiety of glutathione, leaving the glycine residue exposed to the external medium. This result was consistent with those of the in vitro stability study, which indicated that the degradation of glutathione was markedly reduced to the half in 2h upon inclusion in alpha-CyD. Overall, these results show the possibility of protecting specific peptide groups by their inclusion in CyDs as well as the utility of NMR experiments for the understanding of this stabilization strategy.
Garcia-Fuentes
M
M
Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, Santiago de Compostela, Spain.
Trapani
A
A
Alonso
M J
MJ
D002851:Chromatography, High Pressure Liquid; D016503:Drug Delivery Systems / Q000379:methods; D004355:Drug Stability; D020689:Exopeptidases / Q000378:metabolism; D018698:Glutamic Acid / Q000737:chemistry / Q000378:metabolism; D005978:Glutathione / Q000737:chemistry* / Q000378:metabolism; D007700:Kinetics; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D008956:Models, Chemical; D011485:Protein Binding; D013678:Technology, Pharmaceutical; D047391:alpha-Cyclodextrins / Q000737:chemistry* / Q000378:metabolism; D005723:gamma-Glutamyltransferase / Q000378:metabolism
D047391:alpha-Cyclodextrins; D018698:Glutamic Acid; D005723:gamma-Glutamyltransferase; D020689:Exopeptidases; D005978:Glutathione